TAPPING US MARKET...GLENMARK TIES UP WITH INVAGEN

A A

Glenmark Pharmaceuticals Ltd. said on Thursday that it has entered into an agreement with InvaGen Pharmaceuticals, Inc. for the joint development, filing and marketing of seven generic products for the US market. The product list includes a mixture of off-patent and patent-protected molecules, with annual sales in the US of about US$4.1bn.

As per the agreement, InvaGen will develop and license to Glenmark, seven generic products.

India Infoline News (http://www.indiainfoline.com/news/news.asp?dat=72040)